Visara appoints ophthalmology leaders to advance VIS-101 drug program

Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program
(NASDAQ: AURA) Delayed: 7.01 -0.04 (0.57%)
Previous Close $7.05    52 Week High
Open $7.03    52 Week Low
Day High $7.14    P/E N/A 
Day Low $6.82    EPS
Volume 481,235       

(NASDAQ: FDMT) Delayed: 9.61 -0.24 (2.44%)
Previous Close $9.85    52 Week High
Open $9.82    52 Week Low
Day High $9.98    P/E N/A 
Day Low $9.39    EPS
Volume 529,754       

(NASDAQ: NBP) Delayed: 1.61 -0.14 (8%)
Previous Close $1.75    52 Week High $6.95 
Open $1.75    52 Week Low $6.95 
Day High $1.77    P/E 0.75 
Day Low $1.61    EPS $2.14 
Volume 296,600